Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03285048 · ClinicalTrials.gov registry record · NA
Cognitive Remediation Therapy (CRT) for Adults Treated for Cancer
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT03285048 is a NA study that has completed, run by Yale University. The registered enrollment target is 12 participants.
The verdict
NCT03285048, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
This study is to determine the safety, feasibility and acceptability of an 8-week cognitive remediation training (CRT) in patients treated for cancer. The secondary objective of the study is to estimate the effect size of CRT in improving neurocognitive functioning and quality of life. This is a single-arm proof of concept study. Patients treated for cancer with persistent cognitive complaints will be recruited from the outpatient clinic of the VA Comprehensive Cancer Center, West Haven, CT, Yale Medicine, and greater New Haven community.The active treatment phase will be followed by an assessment at the conclusion of treatment to evaluate changes in cognitive function and quality of life. Participants will be invited back to participate in a final follow-up assessment 2 months later.
Interventions
- BEHAVIORAL Cognitive Remediation Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2017-01 |
| Est. Completion | 2017-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03285048
The ClinicalTrials.gov registry entry for NCT03285048 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cognitive Remediation Therapy is the first listed.
NCT03285048 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03285048 about?
NCT03285048 is a clinical study titled "Cognitive Remediation Therapy (CRT) for Adults Treated for Cancer". This study is to determine the safety, feasibility and acceptability of an 8-week cognitive remediation training (CRT) in patients treated for cancer. The secondary objective of the study is to estimate the effect size of CRT in improving neurocognitive functioning and quality of life. This is a sin...
What is the current status of trial NCT03285048?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2017-01. Estimated completion is 2017-09.
What interventions are being tested in trial NCT03285048?
The interventions under investigation include: Cognitive Remediation Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT03285048?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.